These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38212126)

  • 41. CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis.
    Wang K; Chen X; Lin P; Wu J; Huang Q; Chen ZN; Tian J; Wang H; Tian Y; Shi M; Qian M; Hui B; Zhu Y; Li L; Yao R; Bian H; Zhu P; Chen R; Chen L
    Adv Sci (Weinh); 2024 Aug; 11(29):e2400611. PubMed ID: 38873823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
    Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
    Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.
    Trinh L; Brignole-Baudouin F; Pauly A; Liang H; Houssier M; Baudouin C
    Mol Vis; 2008; 14():2428-34. PubMed ID: 19104678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of the chemokine receptor CCR5 in tick-borne encephalitis.
    Grygorczuk S; Osada J; Parczewski M; Moniuszko A; Świerzbińska R; Kondrusik M; Czupryna P; Dunaj J; Dąbrowska M; Pancewicz S
    J Neuroinflammation; 2016 Feb; 13():45. PubMed ID: 26906062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy.
    Ji S; Chen H; Yang K; Zhang G; Mao B; Hu Y; Zhang H; Xu J
    Biomed Pharmacother; 2020 Sep; 129():110457. PubMed ID: 32887027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis.
    Pervaiz A; Zepp M; Georges R; Bergmann F; Mahmood S; Faiza S; Berger MR; Adwan H
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):73-91. PubMed ID: 32902795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer.
    Giordano G; Parcesepe P; D'Andrea MR; Coppola L; Di Raimo T; Remo A; Manfrin E; Fiorini C; Scarpa A; Amoreo CA; Conciatori F; Milella M; Caruso FP; Cerulo L; Porras A; Pancione M
    J Exp Clin Cancer Res; 2019 Jan; 38(1):28. PubMed ID: 30670049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
    Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
    Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
    Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A
    Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infiltration of CD8+ T cells containing RANTES/CCL5+ cytoplasmic granules in actively inflammatory lesions of human chronic gastritis.
    Ohtani N; Ohtani H; Nakayama T; Naganuma H; Sato E; Imai T; Nagura H; Yoshie O
    Lab Invest; 2004 Mar; 84(3):368-75. PubMed ID: 14704722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment.
    Brett E; Duscher D; Pagani A; Daigeler A; Kolbenschlag J; Hahn M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.
    Jary M; Liu WW; Yan D; Bai I; Muranyi A; Colle E; Brocheriou I; Turpin A; Radosevic-Robin N; Bourgoin P; Penault-Llorca F; Cohen R; Vernerey D; André T; Borg C; Shanmugam K; Svrcek M
    Mol Oncol; 2022 Jun; 16(11):2260-2273. PubMed ID: 34954864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1.
    Burren S; Reche K; Blank A; Galvàn JA; Dawson H; Berger MD; Zlobec I; Lugli A
    Pathol Res Pract; 2021 Jul; 223():153486. PubMed ID: 34051513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.
    Zhao N; Dang H; Ma L; Martin SP; Forgues M; Ylaya K; Hewitt SM; Wang XW
    Hepatology; 2021 Mar; 73(3):1045-1060. PubMed ID: 32502310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
    Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
    J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancer.
    Kanno H; Miyoshi H; Yoshida N; Sudo T; Nakashima K; Takeuchi M; Nomura Y; Seto M; Hisaka T; Tanaka H; Okuda K; Akagi Y; Ohshima K
    Cancer Sci; 2020 Aug; 111(8):3032-3044. PubMed ID: 32449240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during influenza A infection in mice.
    Tavares LP; Garcia CC; Gonçalves APF; Kraemer LR; Melo EM; Oliveira FMS; Freitas CS; Lopes GAO; Reis DC; Cassali GD; Machado AM; Mantovani A; Locati M; Teixeira MM; Russo RC
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L655-L670. PubMed ID: 31995405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.